Tech Titans Prepare to Unite at Trump Inauguration Ceremony

US
Published:

The upcoming inauguration of President-elect Donald Trump is expected to attract significant attention, particularly due to the presence of major figures from the technology and business sectors, including Elon Musk, Jeff Bezos, and Mark Zuckerberg. According to an NBC News report, the three billionaire moguls could be seen sitting together at the event, indicating their increased alignment with Trump's platform.

Elon Musk, recognized as the world's richest person, has become a notable supporter, contributing over $250 million to Trump's campaign. He is also set to co-lead a new government efficiency department aimed at reforming the federal workforce. At the same time, Musk faces criticism for potentially using his social media platform, X, to disseminate misinformation supporting Trump.

Jeff Bezos, founder of Amazon and owner of The Washington Post, has made waves by blocking editorial endorsements of presidential candidates just before the paper was about to endorse Kamala Harris, who ultimately lost to Trump. Bezos also recently contributed $1 million to Trump’s inauguration fund, marking a significant departure from his previous low-profile approach.

Zuckerberg, CEO of Meta, has made similar moves to align with conservative views, eliminating the company's fact-checking program and easing restrictions on political content. He is even co-hosting a pre-inaugural reception alongside prominent Republican donor Miriam Adelson.

While the technology sector provides substantial financial backing for Trump, leading to questions about potential conflicts of interest, music stars such as Carrie Underwood and the Village People are also scheduled to perform, emphasizing the theme of unity amidst political division.

The inauguration ceremony will take place on January 20, coinciding with Martin Luther King Day, and marks a stark contrast to the events of January 6, 2021, when the Capitol was stormed by Trump's supporters.

Weekly Newsletter

News summary by melangenews

Loading...

More from United States

Tragic Collision of Passenger Plane and Military Helicopter in Washington Claims 67 Lives

A catastrophic midair collision between a passenger plane and a military helicopter in Washington D.C. on Wednesday resulted in the deaths of all 67 individuals on board. The incident involved American Airlines flight 5342, which was a Bombardier CRJ-700 carrying 60 passengers and four crew members, and a military Sikorsky H-60 Black Hawk helicopter occupied by three service members. The collision occurred over the Potomac River at approximately 8:48 PM local time while the plane was making its final approach to Ronald Reagan Airport. Eyewitness reports indicated that the helicopter veered dangerously close to the aircraft before the impact, causing both to explode in midair. Emergency teams recovered 28 bodies from the plane and one from the helicopter, confirming that no survivors emerged from the wreckage. American Airlines expressed its condolences and stated that it is cooperating with investigation efforts, while President Donald Trump commented on the tragedy, stating it "seemed avoidable" given the clear weather conditions and routine approach procedure. A joint investigation by civil and military authorities is underway to determine the accident's cause.
US

FDA Approves Revolutionary Bioengineered Blood Vessel for Trauma Treatments

The U.S. Food and Drug Administration (FDA) has approved a groundbreaking bioengineered blood vessel aimed at addressing the needs of trauma patients. Developed by North Carolina-based Humacyte, this vessel is designed to integrate with a patient’s body over time, providing a solution for individuals who have suffered severe injuries that impede blood circulation, particularly in cases of amputation. According to founder and CEO Laura Niklason, traditional treatments using veins are often inadequate, especially when patients cannot provide usable options from their own bodies. The FDA approval follows extensive testing involving 51 civilian and 16 military patients, revealing that nearly 92% of the engineered vessels remained functional after 30 days, compared to 79% for synthetic alternatives. Additionally, the infection rate for the bioengineered vessels was under 1%, significantly lower than the over 8% rate associated with synthetic grafts, as published in the journal JAMA Surgery. While the approved application is limited to trauma cases, Humacyte is exploring additional uses for its technology, including potential applications in kidney dialysis and peripheral artery disease.
US

Trump Plans to Detain 30,000 Migrants at Guantanamo Bay

Former President Donald Trump has outlined a controversial plan to detain up to 30,000 migrants at the Guantanamo Bay detention facility if he is re-elected in 2024. According to a statement released by Trump's campaign, this measure aims to address illegal immigration and bolster national security. This proposal comes amidst intensifying discussions on immigration policies in the United States, reflecting Trump's previously embraced hardline stance during his presidency. Trump's administration was marked by strict immigration measures, including family separations and the construction of barriers along the U.S.-Mexico border. Critics of the plan have raised concerns about humanitarian implications and the legality of detaining a large number of migrants indefinitely. Legal experts argue that such actions could face significant pushback in courts. The proposal reflects a broader trend among certain political leaders advocating for stringent immigration control as a response to increasing cross-border migration. As the 2024 presidential election approaches, Trump's immigration policy is expected to be a focal point of debate among candidates.
US